最新 100 件のみ表示中(全 4068 件)。 古い論文は Knowledge/ の MOC / Entity ページから辿れます。
2026-07-27 (7 papers)
- Shin et al. ACSNano 2026 — Neutrophil-Like Mitochondria Enable Blood-Brain Barrier Transmigration and Neuroprotection. (Basic-Neutrophil and myeloid cell)
- Yue et al. JNeuroinflammation 2025 — Inhibition of neutrophil extracellular traps alleviates blood-brain barrier disruption and cognitive dysfunction via … (Basic-Neutrophil and myeloid cell)
- Yang et al. PLoSONE 2023 — A novel co-culture model for investigation of the effects of LPS-induced macrophage-derived cytokines on brain endoth… (Basic-Neutrophil and myeloid cell)
- Jia et al. CellDeathDis 2018 — The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. (Basic-Others)
- Marques et al. CurrBiol 2024 — Lipocalins. (Basic-Others)
- Han et al. Immunity 2026 — Mammary tumors-derived exosomes induce striatal NF-κB signaling, microglial reactivity, and anxiety/depression-like b… (Basic-Others)
- Goo et al. JControlRelease 2026 — Single-ligand dual-targeting lipid nanoparticles for therapeutic mRNA delivery to glioblastoma across the blood-brain… (Clinical-Others)
2026-07-25 (2 papers)
- Xin et al. CellBiomater 2026 — IL-4/C1q activated astrocyte-derived extracellular vesicles promote stroke infarct recovery by recruiting peripheral … (Basic-Extracellular vesicles)
- Wang et al. NatBiomedEng 2026 — Super homotypic targeting by surface engineering of extracellular vesicles. (Basic-Extracellular vesicles)
2026-07-21 (12 papers)
- Silva et al. FrontImmunol 2026 — Extracellular vesicles as prognostic biomarkers results of a neoadjuvant chemoimmunotherapy clinical trial in stage (Basic-Extracellular vesicles)
- Li et al. JCachexiaSarcopeniaMuscle 2026 — Cigarette Smoke-Exposed Alveolar Epithelial Cell-Derived Exosomes Exacerbate Skeletal Muscle Dysfunction Through HDAC… (Basic-Extracellular vesicles)
- Muro et al. SciAdv 2026 — A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle-based mRNA vaccines. (Basic-Immunotherapy)
- Song et al. SciAdv 2026 — Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8+ T cell surveillance in lun… (Basic-Immunotherapy)
- Guo et al. Biomaterials 2026 — Synergistic immunotherapy of NSCLC enabled by a biomimetic nanodelivery system for autophagy-mediated MDSC reprogramm… (Basic-Neutrophil and myeloid cell)
- Suissa et al. NatMed 2026 — Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling. (Basic-Others)
- de Marinis et al. LungCancer 2026 — Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert pan… (Clinical-NSCLC-Driver negative)
review - Liu et al. SciAdv 2026 — Albumin binding improves the pharmacokinetics and therapeutic efficacy of a 177Lu-labeled HER2 Fab radioconjugate. (Clinical-NSCLC-HER2)
- Mi et al. ExpertOpinBiolTher 2026 — Advances in antibody-drug conjugate-based combination therapy strategies for non-small cell lung cancer. (Clinical-Novel modalities)
review - Petrelli et al. LungCancer 2026 — Interstitial lung disease in patients treated with antibody-drug conjugates: a review. (Clinical-Novel modalities)
review - Amick et al. NatRevMolCellBiol 2026 — Cellular and signalling mechanisms that regulate the blood-brain barrier. (Clinical-Others)
review - Cutter et al. SciAdv 2026 — Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis. (Clinical-Respiratory diseases)
2026-07-20 (1 papers)
- King et al. NatRevDrugDiscov 2026 — Induced proximity-based therapeutic modalities. (Clinical-Others)
review
2026-07-19 (78 papers)
- DallOlio et al. ClinCancerRes 2026 — The role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer (Basic-Liquid-biopsy)
- Gal et al. ClinCancerRes 2026 — Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma (Basic-Liquid-biopsy)
- Wang et al. SciAdv 2026 — A Scalable Deep-Learning Framework for Cancer Detection Using Cell-Free DNA Shallow Whole-Genome Sequencing (Basic-Liquid-biopsy)
- He et al. AnnuRevCancerBiol 2022 — Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer (Basic-Neutrophil and myeloid cell)
- Taner et al. CancerRes 2026 — IL-1α Expands SLC2A1-high SPP1high IFN-low Myeloid Cells to Drive Immune Escape and Malignant Transformation of Pre-c… (Basic-Neutrophil and myeloid cell)
- Rubenich et al. CytokineGrowthFactorRev 2021 — Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells. (Basic-Neutrophil and myeloid cell)
review - Quinn et al. MethodMolBiol 2020 — Neutrophil: Methods and Protocols, Third Edition (Basic-Neutrophil and myeloid cell)
- Brandau et al. MethodMolBiol 2021 — Myeloid-Derived Suppressor Cells: Methods and Protocols (Methods in Molecular Biology, Vol. 2236) (Basic-Neutrophil and myeloid cell)
- Tang et al. NatMetab 2026 — Macrophage-derived itaconate is a negative regulator of adipose tissue thermogenesis. (Basic-Neutrophil and myeloid cell)
- Meyerson et al. Poster 2024 — Serine Protease Inhibitors Enhance Neutrophil Survival (Basic-Neutrophil and myeloid cell)
- Chen et al. SSRN 2024 — Circulating cell-in-cell tumor cells with neutrophil signature are hematogenous metastasis-initiating cells (Basic-Neutrophil and myeloid cell)
- Rabas et al. bioRxiv 2024 — Cancer-driven neutrophil priming couples systemic epithelial regenerative programs with pre-metastatic niche formation (Basic-Neutrophil and myeloid cell)
- Alkan et al. bioRxiv 2026 — S100A9-dependent CXCR2hi neutrophils mediate systemic immune suppression and (Basic-Neutrophil and myeloid cell)
- 大坂 et al. 血栓止血誌 2021 — Neutrophil extracellular traps and cancer (Basic-Neutrophil and myeloid cell)
- 三好 et al. 血栓止血誌 2022 — Measurement method and clinical significance of neutrophil extracellular traps (NETs) (Basic-Neutrophil and myeloid cell)
- Scaparone et al. CancerDiscov 2026 — EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling throug… (Basic-Oncogene and genetics)
- Zang et al. CancerRes 2026 — Label-Free Prediction of EGFR Mutation Status Using Fluorescence Lifetime Imaging and Deep Learning in Lung Adenocarc… (Basic-Oncogene and genetics)
- Shijubo et al. AmJRespirCritCareMed 2026 — Cryobiopsy Reveals the Architectural Maturity of Tertiary Lymphoid Structures in Lung Cancer. (Basic-Others)
- Min et al. CancerDiscov 2026 — AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors. (Basic-Others)
- Seamon et al. CancerDiscov 2026 — Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant Can… (Basic-Others)
- Alamoudi et al. CancerRes 2026 — From Tissue Specificity to Systemic Cues: Shaping MYC‑Driven Tumor Metabolism. (Basic-Others)
- Hao et al. CancerRes 2026 — Targeting WRN Helicase in Microsatellite Instable Colorectal Cancer Induces Antitumor Immunity through Extrachromosom… (Basic-Others)
- Penisson et al. CancerRes 2026 — Comprehensive Genomic Analysis of Normal and Cancer Cells Elucidates the Elevated Mutation Burden in Cancer (Basic-Others)
- Tarrago et al. CancerRes 2026 — Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis. (Basic-Others)
- Xu et al. CellDeathDiscov 2026 — Wnt signaling-mediated activation of cancer cell stemness in thoracic SMARCA4-deficient undifferentiated tumor cells. (Basic-Others)
- Ke et al. CellOncol(Dordr) 2026 — Exosomal LINC00323 accelerates angiogenesis through activating the MAPK and JAK-STAT pathways by stabilizing CDC5L in… (Basic-Others)
- Swann et al. CellStemCell 2026 — Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation. (Basic-Others)
- Chen et al. ClinCancerRes 2026 — Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell L… (Basic-Others)
- Cipriani et al. ClinCancerRes 2026 — Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer. (Basic-Others)
- Chen et al. DrugDesDevelTher 2020 — Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in P… (Basic-Others)
- Gu et al. Immunity 2026 — Targeting cholesterol esterification sensitizes liver cancer to CD8+ T cell attack by impairing metabolic and redox r… (Basic-Others)
- Lewy et al. Immunity 2026 — Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral patt… (Basic-Others)
- Bharat et al. JAMA 2026 — Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer. (Basic-Others)
- Jong et al. JImmunotherCancer 2026 — Lenalidomide boosts CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2-T cell effector functions via CD28, Notch signaling a… (Basic-Others)
- Zhang et al. JImmunotherCancer 2026 — HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence. (Basic-Others)
- Weickhardt et al. JThoracOncol 2012 — Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene… (Basic-Others)
- Sethakorn et al. JThoracOncol 2026 — Leveraging Vulnerabilities of Molecular Subtypes to Identify Rational Combination Therapies-The Next Wave in Extensiv… (Basic-Others)
- Alvero et al. MethodMolBiol 2021 — Detection of Cell Death Mechanisms (Basic-Others)
- Christian et al. MethodMolBiol 2022 — Cancer Cell Biology: Methods and Protocols (Basic-Others)
- Price et al. NatGenet 2026 — Identifying critical lysines in mammalian histone H3 with high-throughput CRISPR prime editing. (Basic-Others)
- De et al. NatMed 2026 — Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized… (Basic-Others)
- Peng et al. Nature 2026 — Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC. (Basic-Others)
- Zhang et al. Nature 2026 — The mutational landscape of STING-induced immunity. (Basic-Others)
- Fang et al. Neuron 2026 — TGF-β1-induced endothelial transcytosis drives blood-brain barrier leakage during aging. (Basic-Others)
- Srinivasan et al. SLASTechnol 2015 — TEER measurement techniques for in vitro barrier model systems. (Basic-Others)
review - Hu et al. SciAdv 2026 — H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics. (Basic-Others)
- Lassila et al. SciAdv 2026 — Progressive intestinal tumor cell plasticity, Myc activation, and loss of Lgr5+ tumor stem cell lineage commitment up… (Basic-Others)
- Divangahi et al. SciImmunol 2026 — Evolution and development of innate immune memory. (Basic-Others)
review - Cross et al. Science 2026 — A dietary switch promotes sensory neuron–dependent cancer-associated cachexia (Basic-Others)
- Zi et al. SignalTransductTargetTher 2026 — Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells. (Basic-Others)
review - kate et al. bioRxiv 2026 — A Chemically Defined Synthetic Cell Capable of Growth and Replication (Basic-Others)
- Bashir et al. CancerCell 2026 — Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth. (Basic-Tumor microenvironment)
- Liu et al. CancerCell 2026 — Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts. (Basic-Tumor microenvironment)
review - Norgard et al. JImmunotherCancer 2026 — Emergence of a mixed CAF population by FAP-CD3 T-cell engager limits therapeutic efficacy. (Basic-Tumor microenvironment)
- Garcia et al. NatRevCancer 2026 — Mesenchymal stromal/stem cells in tumour initiation, progression and therapy. (Basic-Tumor microenvironment)
review - Yip et al. Science 2026 — ILC2s regulate a fibroblast progenitor niche in the pancreas. (Basic-Tumor microenvironment)
- Risom et al. bioRxiv 2026 — A spatial proteomic atlas of tertiary lymphoid structures in non-small cell lung cancer identifies a novel predictive… (Basic-Tumor microenvironment)
- Travis et al. WHO 2004 — WHO Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (2004) (Clinical-Epidemiology)
- Tsao et al. IASLC 2016 — IASLC Atlas of ALK and ROS1 Testing in Lung Cancer, Second Edition (Clinical-NSCLC-ALK)
- Yue et al. NEnglJMed 2026 — Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer. (Clinical-NSCLC-ALK)
- Reinhorn et al. JTOClinResRep 2026 — Clinical Outcomes for Patients who Received Both Trastuzumab Deruxtecan (T-DXd) and Trastuzumab Emtansine (T-DM1) for… (Clinical-NSCLC-HER2)
- Itchins et al. LungCancer 2026 — Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from t… (Clinical-NSCLC-ROS1)
- Garrido-Castro et al. AnnOncol 2026 — SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with meta… (Clinical-Novel modalities)
- Felip et al. CancerResCommun 2026 — Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-… (Clinical-Novel modalities)
- Amor et al. Cell 2026 — CAR T targets: AI takes the wheel. (Clinical-Novel modalities)
- Baker et al. Cell 2026 — AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy. (Clinical-Novel modalities)
- Zhou et al. CellRepPhysSci 2025 — Challenges and opportunities for lysosome-targeting chimeras (Clinical-Novel modalities)
- Liu et al. CritRevOncolHematol 2026 — TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates. (Clinical-Novel modalities)
review - Abrahimi et al. JExpMed 2026 — Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models. (Clinical-Novel modalities)
- Hofman et al. LungCancer 2026 — New biomarkers for antibody-drug conjugates in lung cancer the pathologist’s perspective. (Clinical-Novel modalities)
review - Yasunaga et al. MethodMolBiol 2026 — Bispecific Antibodies: Methods and Protocols (Clinical-Novel modalities)
- Li et al. MolCancer 2026 — Antibody-drug conjugates in breast cancer: from mechanism to revolutionizing clinical practice. (Clinical-Novel modalities)
review - Fauveau et al. MolTherOncol 2026 — Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncol… (Clinical-Novel modalities)
- Qu et al. NatBiomedEng 2026 — Identifying and reprogramming softness-driven cancer stem-like cells overcomes CAR-T cell resistance in solid tumours (Clinical-Novel modalities)
- Carlino et al. NatMed 2026 — An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial. (Clinical-Novel modalities)
- Jewell et al. NatRevBioeng 2026 — Trial design of CAR T cell therapy for autoimmune diseases (Clinical-Novel modalities)
- Rampotas et al. SciTranslMed 2026 — CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organo… (Clinical-Novel modalities)
- Karnofsky et al. Cancer 1948 — The use of the nitrogen mustards in the palliative treatment of carcinoma (Clinical-Supportive care)